Hussein Khaled - Concepedia

Author

Hussein Khaled

Also Known As

H Khaled, H. Khaled, H. M. Khaled, H.M. Khaled, HUSSEIN KHALED, Hayfa Khaled, Hussein Khaled, Hussein M Khaled, Hussein M. Khaled, Hussein Mustafa Khaled

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Cairo University Children Cancer Hospital European Organisation for Research and Treatment of Cancer Institut Gustave Roussy National Research Centre

About

Hussein Khaled is an author at Cairo University specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	2.4K
2	Immunology	2	2	55
3	Engineering	1	1	52
4	Health Sciences	1	1	50
5	Allergy	1	1	19

Hussein Khaled

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies, Hongchao Pan, Jon Godwin, The Lancet Breast OncologyLong-term EffectsMedicineRandomised TrialGynecology	2012	2K
Eight Cycles of ABVD Versus Four Cycles of BEACOPP<sub>escalated</sub>Plus Four Cycles of BEACOPP<sub>baseline</sub>in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial Patrice Carde, Matthias Karrasch, Catherine Fortpied, Journal of Clinical Oncology	2016	120
Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy Mohamed S. Zaghloul, John P. Christodouleas, Andrew M. Smith, JAMA Surgery	2017	88
Urinary Bladder Cancer Risk Factors in Egypt: A Multicenter Case–Control Study Yun‐Ling Zheng, Sania Amr, Doa’a A. Saleh, Cancer Epidemiology Biomarkers & Prevention	2012	81
Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer Fathia El-Sharkawi, Marwa I. Shabayek, Hussein Khaled Asian Pacific Journal of Cancer Prevention EngineeringSerum ExosomesPathologyExtracellular MicrovesiclesExosomes Levels	2019	52
ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial. Patrice Carde, Matthias Karrasch, Catherine Fortpied, Journal of Clinical Oncology Beacopp PtsPrimary EndpointCancer ManagementClinical EndpointPathology	2012	50
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Invasive Transitional and Squamous Cell Carcinoma of the Bladder: Effect on Survival and Bladder Preservation Hussein Khaled, Hanan E. Shafik, M.S. Zabhloul, Clinical Genitourinary Cancer UrologySurgical OncologyGenitourinary CancerMedicineInvasive Transitional	2014	39
Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer Abdel‐Rahman N. Zekri, Zeinab Hassan, Abeer A. Bahnassy, Asian Pacific Journal of Cancer Prevention	2015	39
Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly Pierre Soubeyran, Hussein Khaled, Marius MacKenzie, Journal of Geriatric Oncology Lymphoid NeoplasiaDiffuse Large B-cellMedicineMalignant Blood DisorderSurgical Pathology	2010	36
A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma Hussein Khaled, Mahmoud Hamza, O. Mansour, European Journal of Cancer UrologySurgical OncologyGenitourinary CancerMedicinePhase Ii Study	2000	31

Page 1